Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit - Reuters
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMlBfbG1yY051SHNUNHdybEJTNEt2VHowMk9UMy1abmpqWnRONG1QNVFKODluMi00Y3NLN2V4ejNxTWZrRGVRc3NGVkRYbVdDRFZJM1VvTktuQzAwTnBIRzlnOUJJQW9STHJzNVh1VmhWalVlcTNudGVIMzQ2ck1kTVBhV3E1RTBReEJpbm8taVZlc0tKLS10d2NEOWhxdUd6RXV4VjFqQUYxNm9VdFdNQWp6OHZpbE1P?oc=5" target="_blank">Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
South African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PMIndia's Sun Pharma wins South Africa approval to launch generic Ozempic - Reuters
India's Sun Pharma wins South Africa approval to launch generic Ozempic Reuters
July 15, 2026 at 05:46 PMNovo Nordisk launches weekly insulin shot Awiqli in India - Reuters
Novo Nordisk launches weekly insulin shot Awiqli in India Reuters
July 9, 2026 at 06:23 AMIndia's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026 at 12:23 PMIndia's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026 at 04:54 AMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PM